Mental Health Clinics in South Pasadena, FL Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Carole Sharman Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1135 Pasadena Ave S Ste 302, South Pasadena, FL 33707 Phone: 727-341-0097 Fax: 727-343-6419 |
John R. Delaney Md Pa Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1135 Pasadena Ave S, South Pasadena, FL 33707 Phone: 727-344-1476 Fax: 727-344-1477 |
Wendy Lucker Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1135 Pasadena Ave S Ste 300, South Pasadena, FL 33707 Phone: 541-350-7041 |
Lori Prince Lcsw Pa Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1135 Pasadena Ave S Ste 311, South Pasadena, FL 33707 Phone: 727-458-9506 Fax: 954-944-2019 |
Applied Behavior Change Corp Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1135 Pasadena Ave S Ste 112, South Pasadena, FL 33707 Phone: 973-873-8558 |
Braved Behavioral Health Institute Inc Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1135 Pasadena Ave S, 111, South Pasadena, FL 33707 Phone: 727-560-0607 Fax: 877-287-1083 |
News Archive
Melbourne researchers show the body's ability to fight novel coronavirus
Melbourne researchers have mapped immune responses from one of Australia's first novel coronavirus (COVID-19) patients, showing the body's ability to fight the virus and recover from the infection.
Sadness often increases people's craving to smoke, shows study
What drives a person to smoke cigarettes - and keeps one out of six U.S. adults addicted to tobacco use, at a cost of 480,000 premature deaths each year despite decades of anti-smoking campaigns?
NCI grants more than $4.2 million to launch Cancer Epitope Database and Analysis Resource
Researchers are about to welcome a new one-stop shop for crucial information on how the immune system targets cancers.
First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval
The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.
ALS Association, AAN to honor KCL neurologist with Essey Award
The American Academy of Neurology and the ALS Association are awarding the 2012 Sheila Essey Award: An Award for ALS Research to Christopher Shaw, MBChB, MD, FRACP, with the Institute of Psychiatry at King's College London. Shaw will receive the award during the Academy's 64th Annual Meeting, April 21-28, 2012, in New Orleans.
› Verified 6 days ago